SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-22-009489
Filing Date
2022-02-25
Accepted
2022-02-25 16:36:45
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea156102-s3_adialpharm.htm S-3 390097
2 OPINION OF BLANK ROME LLP ea156102ex5-1_adialpharm.htm EX-5.1 8121
3 CONSENT OF FRIEDMAN LLP ea156102ex23-1_adialpharm.htm EX-23.1 1904
4 FILING FEE TABLE ea156102ex-fee_adialpharm.htm EX-FILING FEES 14120
5 GRAPHIC image_001.jpg GRAPHIC 6020
6 GRAPHIC ex5-1_001.jpg GRAPHIC 2539
  Complete submission text file 0001213900-22-009489.txt   427522
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263037 | Film No.: 22680838
SIC: 2834 Pharmaceutical Preparations